TMOD Stock Overview
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Thermo Fisher Scientific Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$28.50 |
| 52 Week High | US$28.50 |
| 52 Week Low | US$28.50 |
| Beta | 0.79 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 5.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| TMOD | AR Life Sciences | AR Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how TMOD performed against the AR Life Sciences industry.
Return vs Market: Insufficient data to determine how TMOD performed against the AR Market.
Price Volatility
| TMOD volatility | |
|---|---|
| TMOD Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in AR Market | 0% |
| 10% least volatile stocks in AR Market | 0% |
Stable Share Price: TMOD's share price has been volatile over the past 3 months compared to the AR market.
Volatility Over Time: Insufficient data to determine TMOD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 122,000 | Marc Casper | www.thermofisher.com |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
Thermo Fisher Scientific Inc. Fundamentals Summary
| TMOD fundamental statistics | |
|---|---|
| Market cap | US$196.16b |
| Earnings (TTM) | US$6.14b |
| Revenue (TTM) | US$42.37b |
32.0x
P/E Ratio4.6x
P/S RatioIs TMOD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMOD income statement (TTM) | |
|---|---|
| Revenue | US$42.37b |
| Cost of Revenue | US$25.13b |
| Gross Profit | US$17.24b |
| Other Expenses | US$11.10b |
| Earnings | US$6.14b |
Last Reported Earnings
Sep 28, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.04 |
| Gross Margin | 40.68% |
| Net Profit Margin | 14.48% |
| Debt/Equity Ratio | 71.9% |
How did TMOD perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield9%
Payout RatioDoes TMOD pay a reliable dividends?
See TMOD dividend history and benchmarks| Thermo Fisher Scientific dividend dates | |
|---|---|
| Ex Dividend Date | Dec 13 2024 |
| Dividend Pay Date | Jan 15 2025 |
| Days until Ex dividend | 21 days |
| Days until Dividend pay date | 54 days |
Does TMOD pay a reliable dividends?
See TMOD dividend history and benchmarks